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HIV-1 Nef accelerates the development of AIDS in
HIV-infected individuals (Dyer et al., 1999). Analysis of
Nef alleles from HIV-1-infected individuals suggests thatSummary
the temporal control of MHC-I downregulation corre-
lates with the two broad clinical stages of AIDS (Carl etThe HIV-1 Nef-mediated downregulation of cell sur-
al., 2001). Nef alleles isolated from asymptomatic indi-face MHC-I molecules to the trans-Golgi network
viduals during early infection efficiently downregulate(TGN) enables HIV-1 to escape immune surveillance.
MHC-I, whereas Nef alleles from individuals followingHowever, the cellular pathway used by Nef to down-
progression to AIDS are impaired in MHC-I downregula-regulate MHC-I is unknown. Here, we show that Nef
tion. These data indicate HIV-1 Nef-mediated immuno-and PACS-1 combine to usurp the ARF6 endocytic
evasion during early infection is a key factor in the devel-pathway by a PI3K-dependent process and downregu-
opment of AIDS. Indeed, Nef-mediated downregulationlate cell surface MHC-I to the TGN. This mechanism
of MHC-I protects HIV-infected cells from killing by CTLrequires the hierarchical actions of three Nef motifs—
in vitro (Collins et al., 1998). Moreover, studies with ma-the acidic cluster 62EEEE65, the SH3 domain binding site
caques infected with simian immunodeficiency viruses72PXXP75, and M20—in controlling PACS-1-dependent
(SIV) that express a mutated Nef designed specificallysorting to the TGN, ARF6 activation, and sequestering
to disable MHC-I downregulation reveal that only SIVinternalized MHC-I to the TGN, respectively. These
isolates that revert to the native sequence develop sim-data provide new insights into the cellular basis of
ian AIDS (Munch et al., 2001). Together, these resultsHIV-1 immunoevasion.
further suggest that Nef-mediated MHC-I downregula-
tion provides a selective advantage for viral replication inIntroduction
vivo. Yet despite the importance of HIV-1 Nef-mediated
MHC-I downregulation, the cellular pathway and traf-The adaptive immune response against HIV-1 and other
ficking machinery usurped by Nef to downregulatepathogenic viruses requires members of the class I ma-
MHC-I are largely unknown.jor histocompatibility complex (MHC-I) to present viral
Recent studies suggest that Nef downregulates cellantigens on the surface of infected cells. Antigen pre-
surface CD4 and MHC-I by different mechanisms (forsentation by MHC-I targets destruction of infected cells
reviews, see Doms and Trono, 2000; Geyer et al., 2001).by CD8 cytotoxic T lymphocytes (CTL). To counteract
Nef directly couples CD4 to clathrin-mediated endocyticthe MHC-I/CTL network, pathogenic viruses have devel-
machinery involving clathrin, dynamin, and the clathrinoped elaborate immunoevasive tools to prevent antigen
adaptor AP-2, thus directing CD4 endocytosis viapresentation. One of these tools is the downregulation
clathrin-coated pits to early endosomes, late endo-of cell surface MHC-I. Nearly every step in the assembly
somes, and eventually lysosomes for degradation (for
and trafficking of newly synthesized MHC-I in infected
review, see Marsh and Pelchen-Matthews, 2000). But
cells represents a potential target for ablating MHC-I
Nef does not downregulate MHC-I through this classical
cell surface expression (for review, see Ploegh, 1998). clathrin-mediated endosomal pathway, since MHC-I in-
Yet how HIV-1 downregulates MHC-I to evade immune ternalization is not inhibited by a dominant-negative dy-
surveillance has remained elusive. namin I (Le Gall et al., 2000). Instead, Nef-induced
Large DNA viruses carry multiple genes that encode MHC-I, but not CD4, downregulation depends on a novel
inhibitors of various stages of the antigen presentation sorting protein, PACS-1 (phosphofurin acidic cluster
pathway. These are mostly aimed at interfering with pro- sorting protein-1) (Wan et al., 1998; Piguet et al., 2000;
teosomal processing of antigenic peptides, with peptide Crump et al., 2001). PACS-1 is required for the Nef-
transport across the lumen of the ER, and with the reten- mediated downregulation of MHC-I to the TGN by means
tion, dislocation, and destruction of class I molecules of binding to the Nef 62EEEE65 acidic cluster (Piguet et
in the ER and early secretory compartments (for reviews, al., 2000; Crump et al., 2001). Two additional Nef sorting
see Ploegh, 1998; Tortorella et al., 2000). In contrast, motifs are critically important for MHC-I downregulation:
the genome size constraints of small RNA viruses such an SH3 domain binding site 72PXXP75, and the Met20
as HIV-1 preclude their use of multiple genes to down- within the amphipathic  helix (for review, see Geyer et
regulate MHC-I. Instead, HIV-1 uses its multifunctional al., 2001). While both these motifs bind protein kinases
early gene product Nef to attenuate MHC-I cell surface and are thus implicated in cellular signaling, the molecu-
expression by endocytosis of class I molecules from lar mechanism of their role in MHC-I downregulation to
the TGN is unclear.
One clue lies in a previous morphological demonstra-1Correspondence: thomasg@ohsu.edu
Cell
854
tion of the codistribution of MHC-I and the small GTPase a–c and d–f). Expression of 2-D176A blocked Nef’s
ability to redistribute CD4 to late endosomes and lyso-ADP ribosylation factor 6 (ARF6) (Radhakrishna and
somes, as expected, but it did not affect MHC-I down-Donaldson, 1997). Members of the ARF family, notably
regulation, which was indistinguishable from that ob-ARF1-3, play multiple roles in regulating vesicle budding
served in cells expressing Nef alone (Figure 1A, g–i).and in recruiting vesicle clathrin and COP-I coat pro-
Identical results were obtained by expressing a domi-teins. ARF6, however, does not recruit these coats but
nant-negative dynamin, DynI-K44E, confirming the im-rather connects vesicle trafficking with actin cytoskele-
portance of the clathrin-dependent endocytosis for Nef-tal rearrangements (for review, see Chavrier and Goud,
mediated downregulation of CD4 but not MHC-I (data1999). Endocytosis and recycling of proteins through
not shown and Le Gall et al., 2000). By contrast, GTPthe ARF6 endosomal compartment is regulated by the
bound ARF6-Q67L specifically blocked the Nef-medi-GTP/GDP bound state of ARF6, as determined in cellular
ated redistribution of MHC-I to the TGN but did not affectstudies by expressing dominant-negative mutants of
CD4 downregulation to late endosomes and lysosomesARF6 deficient either in GTP hydrolysis (ARF6-Q67L)
(Figure 1A, j–l). In agreement with previous data (Crumpor in GDP exchange (ARF6-T27N) (Radhakrishna and
et al., 2001), cells coexpressing Nef and PACS-1AdmutDonaldson, 1997).
(a dominant-negative PACS-1 with an abolished bindingIn this study, we examined whether the ARF6 endoso-
to AP-1) displayed normal Nef-induced CD4 downregu-mal pathway accompanied by GTP hydrolysis of ARF6
lation to lysosomes, while MHC-I was retained on the
is used in conjunction with PACS-1 in HIV-1 Nef-induced
cell surface (Figure 1A, m–o).
MHC-I downregulation. We also determined how major
To test whether the selective action of 2-D176A,
Nef sorting motifs crucial for MHC-I downregulation— ARF6-Q67L, or PACS-1Admut on Nef-induced CD4 and
M20, 62EEEE65, and 72PXXP75—are incorporated in this pro- MHC-I redistribution was due to inhibition of endocyto-
cess. Our results show that Nef downregulates MHC-I sis of these membrane proteins from the cell surface,
through the PI3K-mediated ARF6 endosomal pathway we measured CD4 and MHC-I internalization rates using
and that the three Nef sorting motifs cooperate in an quantitative assays. The initial rate of Nef-induced up-
ordered manner to achieve this downregulation. Taken take of both CD4 and MHC-I increased by approximately
together, these results describe the cellular basis for 3-fold or 2-fold, respectively (Figure 1B). When Nef and
MHC-I downregulation in HIV-1 immunoevasion. 2-D176A were coexpressed, the CD4 internalization
rate was reduced to control cell levels, whereas the
MHC-I internalization rate remained equivalent to that
Results in the cells expressing Nef alone. In contrast, in cells
coexpressing either Nef and ARF6-Q67L or Nef and
Two Separate Endocytic Pathways Are Involved PACS-1Admut, the rate of CD4 internalization was not
in Nef-Induced Downregulation of CD4 and MHC-I altered compared with cells expressing Nef alone, while
HIV-1 Nef-mediated CD4 downregulation proceeds the rate of MHC-I internalization was dramatically re-
through a classical clathrin-dependent endocytic path- duced to that measured in control cells (Figure 1B).
way that leads to CD4 degradation in lysosomes. But These data strongly suggest that Nef-induced downreg-
ulation of CD4 and MHC-I proceeds by two separatehow MHC-I is downregulated by Nef is much less clear.
endocytic pathways: the CD4 pathway uses the classi-To establish which endocytic pathway is used by Nef
cal AP-2/dynamin/clathrin-associated machinery, andto downregulate MHC-I, we analyzed the effects of Nef
MHC-I uses a nonclathrin pathway involving ARF6 andcoexpressed with dominant-negative sorting proteins
PACS-1.on the distribution of CD4 and MHC-I in HeLa-CD4 cells.
We next examined the effects of the dominant-nega-These sorting proteins—including 2-D176A, a mutated
tive 2-D176A and ARF6-Q67L on the localization ofsubunit of the heterotetrameric clathrin adaptor protein
cell surface CD4 and MHC-I in HIV-1-infected cells toAP-2, and ARF6-Q67L, an ARF6 mutant defective in GTP
establish whether CD4 and MHC-I are downregulatedhydrolysis that localizes to the plasma membrane—were
along the same two separate pathways as in Nef-previously shown to inhibit clathrin-dependent or
expressing cells. In agreement with data describedclathrin-independent endocytosis, respectively (Radha-
above (Figure 1A), expression of ARF6-Q67L in HIV-1-krishna and Donaldson, 1997; Nesterov et al., 1999). Our
infected HeLa-CD4 cells did not affect the redistributionrationale for evaluating the contribution of the ARF6-
of CD4 to lysosomes but did cause MHC-I retention on
mediated pathway in Nef-induced MHC-I downregula-
the cell surface (Figure 1C, a and b). By contrast, HIV-1-
tion was based on previous morphological data showing infected cells expressing 2-D176A maintained CD4 on
a partial overlap of the MHC-I with the ARF6 compart- the cell surface while redistributing MHC-I to the TGN
ment at steady-state (Radhakrishna and Donaldson, (Figure 1C, c and d). Together, these data show that the
1997). separate downregulation of CD4 and MHC-I along the
HeLa-CD4 cells expressing Nef showed efficient re- AP-2/clathrin-dependent and clathrin-independent,
distribution of cell surface CD4 into internal compart- ARF6-mediated pathways, respectively, takes place
ments corresponding to lysosomes and late endosomes both in HIV-1-infected and Nef-expressing cells.
(Piguet et al., 1999). In our results, Nef expression simi-
larly caused redistribution of cell surface CD4 to these MHC-I Normally Internalizes and Recycles
compartments, whereas cell surface MHC-I was redis- via an ARF6 Pathway
tributed into a paranuclear area that overlapped with Our finding that HIV-1/Nef downregulates MHC-I through
the ARF6 pathway raises the question of whether MHC-Ithe TGN membrane marker TGN46 (compare Figure 1A,
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Figure 1. MHC-I and CD4 Are Downregulated by HIV-1 Nef along the Two Separate Endocytic Pathways
(A) Immunofluorescence microscopy of CD4 and MHC-I in HeLa-CD4 cells infected with VV:WT (a–c) or recombinant vv expressing either Nef
(d–f) (moi  10), Nef and 2-D176A (g–i), Nef and ARF6-Q67L (j–l), or Nef and PACS-1Admut (m–o). Double infections used a total moi of 10.
(Nef, moi  3; dominant-negative, moi  7). Cells were infected for 4 hr and then fixed, permeabilized, and stained with either anti-CD4 (a,
d, g, j, m) or double-stained with anti-MHC-I (b, e, h, k, n) and anti-TGN46 (c, f, i, l, o) and visualized with species-specific fluorescently tagged
secondary antibodies. Identical results were obtained using monoclonal or polyclonal anti-MHC-I. Exposure times were reduced 2-fold for
cells with downregulated MHC-I or CD4 to compensate for the greatly increased paranuclear staining. Scale bar equals 10 m.
(B) Initial internalization rates of CD4 and MHC-I in HeLa-CD4 cells infected with wt (control) or recombinant vv as in (A). CD4 internalization
(top) was measured using 100 ng/ml 125I-Q4120 over the indicated times at 37C, as previously described (Blagoveshchenskaya et al., 1999).
MHC-I internalization (bottom) was measured by cell surface biotinylation as described in Experimental Procedures. The amounts of internalized
CD4 and MHC-I are expressed as percent of total cell surface-associated CD4 or MHC-I, correspondingly. Representative blots are shown
at the bottom. Error bars represent the mean  SE of three independent experiments.
(C) HeLa-CD4 cells were infected with HIV-1-PLAP (moi  0.05) for 24 hr and, following reculture for another 24 hr, infected with adenoviruses
expressing ARF6-Q67L-ha (a and b) or 2-D176A-ha (c and d) (moi  1) for 48 hr. Cells were then fixed, permeabilized, and labeled with
either anti-CD4 (a and c) or anti-MHC-I (b and d). Insets show the cells labeled with anti-ha (red) and anti-PLAP (blue). Note in b that MHC-I
is downregulated only in the cell infected with HIV-1-PLAP but not expressing ARF6-Q67L-ha (outlined). Secondary antibodies used were
goat anti-mouse IgG1-TxR (anti-HA), anti-IgG2a-FITC (anti-CD4 and anti-MHC-1), and goat anti-rabbit IgG-Alexa Fluor 350 (anti-PLAP). Scale
bar equals 10 m.
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tosis proceeds via the classic clathrin-mediated path-
way (Figure 2A).
Quantitative biotinylation assays also showed that in-
ternalized MHC-I molecules recycle to the cell surface
from a primaquine (Pq)-sensitive, ARF6-regulated com-
partment (Figure 2B). In agreement with previous data
(Reid and Watts, 1990), we found that the initial rate of
constitutive MHC-I recycling in HeLa-CD4 cells (54%/
min  4%/min) was reduced by 75% (13%/min  1%/
min) in the presence of the deacidifying agent Pq. MHC-I
recycling was similarly inhibited following expression of
GDP bound ARF6-T27N, which localizes mostly to an
internal tubulovesicular compartment (Figure 4E; Rad-
hakrishna and Donaldson, 1997). Interestingly, extended
chase times showed that constitutively recycled MHC-I
molecules were reinternalized in these cells at a first
order rate of 9.1%/min  0.6%/min—nearly 20 times
greater than the internalization rate measured for the
original cell surface pool (Figure 2A). This more rapid
reinternalization rate of recycled MHC-I suggests that
only a subpopulation of the total MHC-I molecules un-
dergoes constitutive internalization and recycling and
may reflect the propensity of MHC-I allotypes to differ-
entially internalize and recycle (Cohen et al., 1999).
Figure 2. Constitutive Internalization and Recycling of MHC-I
Nonetheless, these results show that MHC-I undergoes
(A) Internalization. HeLa-CD4 cells were either infected with VV:WT
efficient recycling from a Pq-sensitive ARF6 endosomal(control) or vaccinia recombinants expressing either ARF6-Q67L or
compartment. Similar results were determined using2-D176A (moi 10) for 4 hr. Duplicate dishes of cells infected with
Jurkat CD4 lymphocytes (see Supplemental Figure S1VV:WT were treated with AlF4 (10 mM NaF  50 M AlCl3) for 30
min. The rates of MHC-I internalization were measured using a cell at http://www.cell.com/cgi/content/full/111/6/853/
surface biotinylation assay as described in the legend for Figure DC1), demonstrating that constitutive cycling of MHC-I
1B. Data are expressed as a percent of MHC-I originally present on between the plasma membrane and the ARF6 compart-
the cell surface.
ment is common to many cell types, including those(B) Recycling. Cells were either mock-infected or infected with
that are primary targets for HIV-1 infection in vivo.VV:WT or VV:ARF6-T27N (moi  10). At 4 hr postinfection, cells
were subjected to a cell surface biotinylation/recycling assay as
described in Experimental Procedures. The efficiency of recycling Nef and PACS-1 Combine to Activate ARF6
was calculated as a percent of the internalized MHC-I pool following The finding that both Nef and PACS-1 were indispens-
the first chase of cells at 37C for 30 min in the presence of Pq. able for stimulating MHC-I endocytosis through the
The assays were performed in triplicate. Error bars depict SD. The
ARF6 pathway (Figure 1) raises the possibility that bind-apparent reversal of the MHC-I recycling after 2 min reflects the
ing of Nef to PACS-1 represents a crucial early steprelatively efficient basal MHC-I internalization rate in HeLa-CD4
cells. VV:WT showed no significant difference in internalization or required to activate GTP loading/hydrolysis of ARF6. To
recycling compared to mock-infected cells (data not shown). test this, we measured ARF6 activation by determining
the extent of [32P]GTP loading of hemagglutinin-tagged
ARF6 (ARF6-ha) in 32Pi-metabolically labeled cells ex-
pressing Nef, PACS-1, or both. We found that whenis constitutively sorted through this pathway under basal
expressed on its own, ARF6-ha showed a small basalconditions or diverted to this pathway only during HIV-1/
level of [32P]GTP loading, which was not measurablyNef-induced downregulation. We thus measured the
changed upon ARF6-ha coexpression with either Nefbasal internalization rates of MHC-I both in HeLa-CD4
or PACS-1 (Figure 3). However, a significantly greatercells expressing dominant-negative ARF6 mutants and
amount of [32P]GTP was associated with ARF6 in thein cells pretreated with pharmacological agents that per-
cells expressing ARF6-ha along with Nef and PACS-1.turb the ARF6 pathway. In control HeLa-CD4 cells, bio-
These data suggest that Nef and PACS-1 act synergisti-tinylated MHC-I originally present on the cell surface
cally in the activation of ARF6.was internalized at an initial rate of 0.48%/min 0.02%/
min (Figure 2A). By contrast, in cells expressing ARF6-
Q67L, constitutive MHC-I endocytosis was inhibited by Different Roles of Nef Sorting Motifs
in MHC-I Downregulation75% (0.12%/min 0.04%/min). This inhibition of MHC-I
internalization rate was also observed in cells pretreated Previous reports describe the importance of three Nef
sorting motifs for MHC-I downregulation: the acidicwith the G protein activator AlF4, which is known to
cause redistribution of ARF6 from the endosomal com- cluster 62EEEE65, the SH3 domain binding site 72PXXP75,
and M20 within an amphipathic  helix. However, thepartment to the plasma membrane and to block the
ARF6 pathway (Radhakrishna et al., 1996). However, in precise roles of these signals in Nef-induced MHC-I traf-
ficking remain unknown (for review, see Doms andcells expressing dominant-negative 2-D176A, consti-
tutive MHC-I internalization was not affected, implying Trono, 2000). To understand the functioning of these
sorting motifs and how they relate to the ARF6 pathway,that neither constitutive nor Nef-induced MHC-I endocy-
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tion in cells expressing Nef, NefE4A, NefAXXA, or
NefM20A. Expression of Nef stimulated the rate of
MHC-I internalization approximately 10-fold over the
basal rate in control cells and, as with constitutive MHC-I
endocytosis, Nef-stimulated internalization was blocked
by AlF4 (Figures 4C and 2). Consistent with the morpho-
logical analyses, NefE4A or NefAXXA failed to stimulate
MHC-I endocytosis above levels measured in control
cells (Figures 4B and 4C). These data are therefore con-
sistent with the cell surface distribution of MHC-I seen
by immunofluorescence analysis in cells expressing
NefE4A or NefAXXA and suggest that both 62EEEE65 and
72PXXP75 mediate Nef-induced MHC-I endocytosis.
Surprisingly, NefM20A stimulated MHC-I endocytosis
to a similar extent as wild-type Nef (Figure 4C), despite
its inability to downregulate MHC-I to the TGN. One likely
explanation for the difference between the biochemical
and morphological results is that once MHC-I is internal-
ized in cells expressing NefM20A, it fails to accumulate
in the TGN and instead is rapidly recycled to the plasma
membrane. To test whether this was the case, we first
compared MHC-I recycling rates to the cell surface in
cells expressing Nef or NefM20A (Figure 4D). We found
that in cells expressing Nef, the MHC-I recycling rate
was reduced nearly 5-fold compared with control cells.
Moreover, this Nef-mediated reduction was identical to
the block in recycling caused by expression of the domi-
nant-negative ARF6-T27N, which caused internalized
MHC-I to accumulate in ARF6-T27N-induced tubular en-
dosomal structures (Figure 4E). In contrast, NefM20A
failed completely to impede MHC-I recycling despite its
ability to stimulate MHC-I internalization. These results
imply that failure of NefM20A to downregulate MHC-I toFigure 3. Nef and PACS-1 Stimulate [32P]GTP Loading of ARF6
the TGN results from its inability to prevent the efficient
A7 cells were infected with adenoviruses expressing the indicated
recycling of MHC-I from the ARF6 compartment to thecombinations of ARF6-ha, Nef, PACS-1, ARNO, and ARNOE156K
plasma membrane. To further test this possibility, we(moi  5) for 16 hr and metabolically labeled with [32P]orthophos-
phate. A replicate plate of cells expressing ARF6-ha, Nef, and PACS-1 examined whether NefM20A was capable of downregu-
was treated with 5 M LY294002 for 1 hr prior to lysis. Cells were lating MHC-I to the TGN in cells pretreated with Pq,
then lysed and ARF6-ha immunoprecipitated. 32P-labeled guanine which blocked constitutive MHC-I recycling from the
nucleotides bound to ARF6-ha were resolved by TLC and quantified ARF6 compartment (Figure 2B). Our results show that
by Phosphorimage analysis using NIH Image software. The expres-
treatment of cells with Pq enabled NefM20A to efficientlysion levels of ARF6-ha, Nef, PACS-1, ARNO, and ARNOE156K were
redirect MHC-I to the TGN (Figure 4B). The effect of Pqmonitored by Western blot as shown. The extent of GTP loading of
ARF6-ha was expressed as a percent of the amount of bound was specific for NefM20A, since MHC-I localization was
[32P]GTP divided by the total bound [32P]GTP  [32P]GDP for each not affected in control cells treated with Pq (Figure 4B).
sample. Error bars represent the mean  SE of three independent The most plausible explanation for these data is that,
experiments. unlike the 62EEEE65 and 72PXXP75 motifs implicated in
MHC-I internalization, M20 promotes MHC-I downregula-
tion by both impeding cell surface retrieval of MHC-Iwe examined the cellular distribution of MHC-I in cells
molecules and diverting them instead to the TGN in aexpressing Nef mutants with alanine residues substi-
Pq-sensitive step (Figures 4B and 4D).tuted at either 62EEEE65 (NefE4A), 72PXXP75 (NefAXXA),
or M20 (NefM20A) (Figure 4A). In agreement with previous
data (Greenberg et al., 1998; Mangasarian et al., 1999; The Nef 62EEEE65 and 72PXXP75 Motifs Function
at Different Steps in the MHC-ICrump et al., 2001), cells expressing any of these Nef
mutants showed an accumulation of MHC-I at the cell Downregulation Pathway
Although the above results established the role of M20surface (Figure 4B). Together, these data confirm that
each of these Nef sorting motifs was indispensable for in sequestering internalized MHC-I toward the TGN, they
do not distinguish between the functions of the acidicMHC-I downregulation to the TGN. But they do not dis-
tinguish whether these motifs participate in the same cluster 62EEEE65 and the SH3 domain binding site
72PXXP75, since mutations in either motif destroyed Nef’sor distinct steps required for MHC-I downregulation to
the TGN. ability to increase MHC-I endocytosis and to alter the
steady-state cell surface distribution of MHC-I com-To address whether these three motifs function at
different steps of MHC-I downregulation, we measured pared to control cells (Figures 4B and 4C). We previously
showed that PACS-1 specifically binds to 62EEEE65 andMHC-I internalization rates using cell surface biotinyla-
Cell
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Figure 4. The Effects of Different Nef Sorting Motifs on MHC-I Downregulation
(A) Schematic of HIV-1 Nef and Nef mutants containing alanine substitutions at M20, 62EEEE65, and 72PXXP75.
(B) Cellular localization of MHC-I by immunofluorescence microscopy. A7 cells were infected with VV:WT or vv recombinants expressing either
Nef, NefE4A, NefM20A, or NefAXXA (moi  10). At 4 hr postinfection, cells were fixed, permeabilized, and incubated with anti-MHC-I and
anti-TGN46. The MHC-I and TGN46 staining patterns were visualized using fluorescently labeled secondary antibodies as described in the
legend for Figure 1A. Duplicate plates of cells expressing wt or NefM20A were pretreated with 0.3 mM Pq for 30 min before fixation. Scale
bar equals 10 m.
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that this binding is necessary for both MHC-I downregu- the ability of NefAXXA to downregulate MHC-I to the
lation and for targeting of a Nef-containing type I mem- TGN, whereas overexpression of PI3K* alone had no
brane reporter protein to the TGN (Piguet et al., 2000). effect on MHC-I localization (Figure 5A and data not
Consistent with these findings, we found that Nef itself shown).
was concentrated in the paranuclear area where its dis- Our data suggested that PI3K is a downstream ef-
tribution partially overlapped with the TGN marker AP-1 fector of Nef/PACS-1 that controls activation of ARF6.
(Figure 5B). In contrast, NefE4A, which is unable to bind Given the role of PI3K in the activation and plasma mem-
PACS-1 (Piguet et al., 2000), accumulated in the cell brane recruitment of ARNO (cytohesin-2), an ARF6 gua-
periphery and failed to be localized to the paranuclear nine nucleotide exchange factor (GEF) (Venkateswarlu
region and to direct MHC-I downregulation to the TGN and Cullen, 2000), we next tested the ability of Nef to
(Figures 5A and 5B). The inability of NefE4A to either stimulate PI3K-dependent recruitment of ARNO and
localize to the TGN or to downregulate MHC-I to the ARF6 to the plasma membrane. We first determined
TGN suggests a requirement for PACS-1 in mediating that expression of ARNO increased [32P]GTP loading of
both of these trafficking steps. To test this possibility, ARF6-ha (Figure 3). In contrast, a catalytically inactive
we engineered a chimera, NefE4A-PACS-1, in which ARNO, ARNOE156K (Beraud-Dufour et al., 1998),
NefE4A was fused to PACS-1. Importantly, the fused blocked both ARF6 loading (Figure 3) and the Nef-medi-
PACS-1 restored the ability of NefE4A to both localize ated downregulation of MHC-I (Figure 5A). Next, we de-
to the paranuclear region and to efficiently downregulate termined whether Nef could stimulate membrane recruit-
MHC-I identical to the ability of Nef alone (Figures 5A ment of ARNO, which contains a PH domain that binds
and 5B). Unlike NefE4A, both NefM20A and NefAXXA to phosphatidylinositol(3,4,5)P3 (PIP3) (Venkateswarlu and
concentrated in the paranuclear region, consistent with Cullen, 2000), by coexpressing in cells ARF6-ha and
the lack of effect of these mutations on binding of Nef ARNO-myc in the absence or presence of Nef or the
to PACS-1 (Figure 5B). Together, these data suggest a various Nef mutants (Figure 5C). In this assay, Nef ex-
key role of the 62EEEE65 in priming MHC-I downregulation pression induced recruitment of both ARNO-myc and
by means of the PACS-1/AP-1-mediated targeting of ARF6-ha to plasma membrane ruffles, which reflects
Nef to the TGN.
activation of PI3K and the GTPase. In support of this,
If the 62EEEE65 motif is required for promoting MHC-I
the Nef-induced membrane recruitment of ARNO-myc
downregulation by targeting of Nef to the TGN, how,
and ARF6-ha was blocked by treatment of cells with
then, is the 72PXXP75 site integrated in this process? Our
LY294002. Because LY294002 has no measurable effectprevious studies, which documented a lack of interac-
on the sorting of Nef to the TGN (Figure 5B), these resultstion between PACS-1 and the 72PXXP75 motif (data not
confirm a role for PI3K in the ARNO-catalyzed activationshown and Piguet et al., 2000), suggested a distinct role
of ARF6. Finally, to demonstrate the efficacy of thefor 72PXXP75 in MHC-I downregulation. Consistent with
assay, we examined the ability of the Nef mutants tothis possibility, a NefAXXA-PACS-1 chimera failed to
stimulate membrane recruitment of ARNO-myc anddownregulate MHC-I to the TGN (Figure 5A). Since the
ARF6-ha. As predicted, neither NefE4A, which is unablePXXP site is capable of binding SH3 domains of several
to sort to the TGN, nor NefAXXA, which is unable tosignaling proteins (for review, see Geyer et al., 2001),
affect PI3K, was capable of inducing the recruitment ofthe 72PXXP75 motif of Nef might be a docking site for
ARNO or ARF6. Yet, NefM20A, which stimulates MHC-Imolecules involved in activating GTP hydrolysis of
internalization from the cell surface (Figure 4), inducedARF6. Supporting this idea, inhibition of phosphatidyli-
membrane recruitment of both ARNO-myc and ARF6-nositide 3-kinase (PI3K) activity by treatment of cells
ha, confirming that this Nef mutant effectively stimulateswith LY294002 blocked both Nef-mediated MHC-I
MHC-I endocytosis but fails to sequester internalizeddownregulation (Figure 5A; Swann et al., 2001) and Nef/
molecules to the TGN (Figure 4). Together, these dataPACS-1-mediated [32P]GTP loading of ARF6-ha (Figure
suggest a hierarchy of the Nef sorting motifs in MHC-I3). Because HIV-1 Nef-containing constructs bind to
downregulation that is initiated with binding of 62EEEE65PI3K (Linnemann et al., 2002), these results raised the
to PACS-1, which promotes targeting of Nef to the TGN.possibility that the 72PXXP75 motif may be required for
The TGN targeting is required for the subsequentassociation of Nef with PI3K in order to direct MHC-I
72PXXP75-mediated, PI3K/ARNO-catalyzed activation ofdownregulation. To test this possibility, we engineered
ARF6 and, in turn, stimulating MHC-I endocytosis. Fi-a second chimera, NefAXXA-PI3K*, in which NefAXXA
nally, M20 is required to sequester internalized MHC-Iwas fused to myc-tagged, constitutively active PI3K
from the ARF6 endosomes to the TGN, thus preventing(p110*, see Experimental Procedures). In agreement
with the LY294002 inhibitor data, fused PI3K* rescued efficient recycling of MHC-I to the cell surface.
(C) MHC-I internalization in A7 cells infected with VV:WT (control) or vaccinia recombinants expressing either Nef, NefE4A, NefM20A, or
NefAXXA for 4 hr (moi  10). Internalization rates were measured using a cell surface biotinylation assay as indicated in the legend for Figure
1B and expressed as the percent of biotinylated cell surface MHC-I that was internalized in cells expressing each Nef mutant.
(D) A7 cells infected with VV:WT (control) or recombinant vv expressing either Nef, NefM20A, or ARF6-T27N were subjected to the recycling
assay described for Figure 2B. Assays were performed in triplicate. Error bars depict SD. The net recycling to the cell surface over the course
of the assay is likely due to the slower basal internalization of MHC-I in A7 cells relative to HeLa-CD4 cells (compare with Figure 2).
(E) A7 cells were infected with adenoviruses expressing Nef and ARF6-T27N-ha (moi  5). After 24 hr, the cells were fixed and permeabilized,
and ARF6-T27N-ha and MHC-I were visualized with mAb HA.11 and mAb W6/32, respectively, followed by subtype-specific fluorescently
labeled secondary antibodies.
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Figure 5. PI3K Is a Nef Effector that Mediates ARF6 Activation and MHC-I Downregulation
(A) A7 cells infected with viral vectors expressing either empty vector, Nef, NefE4A, NefE4A-PACS-1, NefAXXA-PACS-1, Nef plus ARNOE156K,
or NefAXXA-PI3K* were processed for immunofluorescence immediately or following treatment of the Nef-expressing cells with 5 M LY294002
for 1 hr (Nef  LY294002). Scale bar equals 10 m.
(B) A7 cells were infected with adenoviruses expressing either Nef, NefE4A, NefE4A-PACS-1, NefAXXA, or NefM20A (moi  5). At 48 hr
postinfection, cells were permeabilized with saponin and the cytosol was extracted for 5 min prior to fixation. Cells expressing Nef were
incubated in the absence or presence of 5 M LY294002 for 1 hr prior to permeabilization. The fixed cells were then double labeled with anti-
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Nef Affects Neither Trafficking of Newly Discussion
Synthesized MHC-I to the Cell Surface
nor Its Degradation We have identified a novel HIV-1 Nef/PACS-1/PI3K/
ARF6 axis that controls MHC-I downregulation. We dis-Most viruses shown to block MHC-I-mediated antigen
presentation do so by rapidly degrading newly synthe- covered that HIV-1 Nef directed MHC-I downregulation
solely by its ability to efficiently internalize cell surfacesized MHC-I in the ER. However, this scenario does not
seem to pertain to HIV-infected cells, since HIV-1 Nef MHC-I from the plasma membrane to the TGN via an
ARF6-mediated pathway. Moreover, our results showedinduces efficient internalization of MHC-I to the TGN
(Greenberg et al., 1998; Le Gall et al., 1998; Piguet et a hierarchical order for the contribution of the three Nef
motifs specifically required for distinct steps in MHC-Ial., 2000; Crump et al., 2001). But are newly synthesized
MHC-I molecules trapped by HIV-1 Nef in the TGN during downregulation: the acidic cluster 62EEEE65, the SH3 do-
main binding site 72PXXP75, and M20 within the N-terminaltransit through the secretory pathway, or do they first
reach the cell surface to be then endocytosed and re- amphipathic  helix. Together, our results both identify
a novel cellular pathway usurped by HIV-1 to downregu-trieved to the TGN? To distinguish between these possi-
bilities, we determined the proportion of newly synthe- late class I molecules and show the specific and orches-
trated roles of the Nef motifs controlling this process.sized class I molecules that arrive at the cell surface in
the presence or absence of Nef and of ARF6 mutants. Whether MHC-I and CD4 downregulation pathways
are separate has long been a question, partly becauseCells were pulse-labeled with [35S]Met/Cys at 18C to
accumulate newly synthesized proteins at the TGN and of attempts to link MHC-I downregulation to the clathrin-
dependent pathway (Le Gall et al., 2000; Swann et al.,then biotinylated either at 37C to monitor TGN-to-PM
export or at 4C as a control. As expected, biotinylated 2001). However, our finding that ARF6-Q67L specifically
blocked MHC-I endocytosis (whereas2-D176A specifi-[35S]MHC-I was not detected on the surface of control
cells, which were shifted to 4C (Figure 6A). By contrast, cally blocked CD4 endocytosis) clearly showed that Nef
usurps distinct sorting pathways to downregulate thewhen cells were biotinylated at 37C, we found signifi-
cant amounts of biotinylated [35S]MHC-I, indicating their two cell surface molecules (Figure 1). Moreover, that
the Nef-induced MHC-I and CD4 pathways constituteefficient transport to the cell surface. Surprisingly, Nef
was unable to measurably block delivery of newly syn- functionally separate processes has been bolstered by
findings of mutually exclusive effects of Nef mutants onthesized MHC-I molecules passing through the cell sur-
face. Moreover, these newly synthesized MHC-I mole- MHC-I and CD4 downregulation (Mangasarian et al.,
1999; Crump et al., 2001). This hypothesis was rein-cules apparently pass through an ARF6-regulated
compartment en route to the cell surface, since ARF6- forced by data showing the selective inhibition of
clathrin-dependent endocytosis, but not MHC-I internal-T27N reduced by nearly 2-fold their trafficking to the
cell surface in either the presence or absence of Nef. ization, by a dominant-negative mutant of dynamin I (Le
Gall et al., 2000, and data not shown). Our findings thatARF6-T27N, however, did not impede all anterograde
transport, as cell surface delivery of furin was unaffected HIV-1 Nef directs downregulation of MHC-I and CD4 via
the ARF6- and clathrin-dependent endocytic pathways,by this mutant (data not shown).
The Nef/PACS-1-mediated downregulation of cell sur- respectively (Figure 1), provide a unifying biochemical
explanation for these various data.face MHC-I to the TGN raises the question as to the
fate of the internalized molecules. Recent studies show Our data suggest a model for the HIV-1 Nef/PACS-1-
mediated MHC-I downregulation that explains the se-that, analogous to HIV-1 Nef, Kaposi’s sarcoma-associ-
ated herpes virus (KHSV) K5 protein also increases en- quential roles of three Nef sorting motifs—the acidic
cluster 62EEEE65, SH3 binding site 72PXXP75, and M20docytosis of MHC-I but, unlike Nef, targets MHC-I
through the dynamin I/clathrin pathway for rapid degra- within an amphipathic  helix. In our model (see Figure
7), MHC-I downregulation is initiated by the binding ofdation in lysosomes (Coscoy and Ganem, 2000). We
therefore compared the stability of cell surface MHC-I the Nef acidic cluster 62EEEE65 to PACS-1/AP-1 (Piguet
et al., 2000; Crump et al., 2001). That the NefE4A-PACS-1in cells expressing either HIV-1 Nef or KHSV K5 (Figure
6B). In agreement with others (Coscoy and Ganem, chimera, but not NefE4A alone, was able to localize to
the TGN and to efficiently downregulate MHC-I (Figure2000), K5 directed efficient degradation of internalized
MHC-I molecules. However, HIV-1 Nef failed to affect 5) supports the requirement for PACS-1 binding to Nef
in this trafficking step. Moreover, our data that NefE4A-the stability of internalized MHC-I molecules compared
to control cells. Together, these results raise the startling PACS-1, but not NefAXXA-PACS-1, downregulates
MHC-I to the TGN imply that the PACS-1/62EEEE65-possibility that HIV-1 Nef control of MHC-I downregula-
tion relies solely on its ability to usurp the ARF6 endo- dependent targeting of Nef to the TGN is a crucial pre-
requisite for the subsequent 72PXXP75-mediated ARF6cytic pathway to redistribute MHC-I from the cell surface
to the TGN. activation (Figure 5). We show that the PI3K inhibitor
Flag (mAb M2) and anti-AP-1 followed by incubation with fluorescently labeled secondary antibodies (goat anti-IgG1-FITC [Nef/Flag] and goat-
anti-IgG2b [AP-1]).
(C) HeLa-CD4 cells coexpressing ARNO-myc and ARF6-ha were coinfected with additional adenoviruses expressing either Nef, NefE4A,
NefAXXA, or NefM20A, fixed, and processed for immunofluorescence using anti-myc mAb 9E10 and a pAb anti-ha followed by fluorescently
labeled secondary antibodies. Cells expressing ARNO-myc, ARF6-ha, and Nef were incubated in the presence or absence of 5 M LY294002
for 1 hr prior to fixation. Scale bar equals 10 m.
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Figure 7. Model of HIV-1 Nef-Mediated MHC-I Downregulation
Shown are the key steps examined in this work.
(1) Binding of Nef acidic cluster 62EEEE65 to PACS-1/AP-1 targets
Nef to the TGN.
(2) Sorting of Nef to the TGN primes the 72PXXP75 motif as shown
by the star.
(3) Primed Nef activates PI3K as shown by the arrow.
(4) PI3K-catalyzed formation of PIP3 at the cell periphery as shown
by the circles.
(5) Recruitment of an ARF6 GEF (ARNO) to PIP3-containing mem-
brane.
(6) ARNO-mediated activation of ARF6 as shown by the arrow.
(7) ARF6-dependent increase in the rate of MHC-I endocytosis from
the cell surface.
(8) Nef M20-dependent block in MHC-I recycling from the ARF6 com-
partment to the cell surface.
(9) Delivery of internalized MHC-I molecules to the TGN. See Discus-
sion for details.
LY294002 blocks several steps required for ARF6 activa-
tion, supporting a key role for PI3K as a Nef effector
controlling MHC-I downregulation. These include the
[32P]GTP loading of ARF6 (Figure 3) as well as recruit-Figure 6. TGN-to-PM Export and Stability of MHC-I
ment of both ARNO—which contains a PH domain that(A) At 18 hr postinfection, HeLa-CD4 cells infected with adenovi-
selectively binds to PIP3 (Venkateswarlu and Cullen,ruses expressing the indicated constructs (moi  10) were pulse-
labeled with [35S]Met/Cys for 10 min at 37C and transferred to 18C 2000)—and ARF6 to membrane ruffles (Figure 5) and
for 3 hr. Cells were then biotinylated with 0.5 mg/ml NHS-SS-Biotin the increased rate of MHC-I internalization (data not
either at 4C as controls or at 37C for 45 min and lysed, and biotinyl- shown). Moreover, the ability of NefAXXA-PI3K*, but not
ated proteins were collected with streptavidin-agarose beads. An
NefAXXA or PI3K* alone, to downregulate MHC-I sug-aliquot from each lysate was removed to monitor the amount of
gests one essential role of the 72PXXP75 motif is to acti-[35S]Met/Cys-labeled MHC-I by fluorography (input) by immunopre-
vate and target PI3K. The activation of PI3K occurscipitation with anti-MHC-I (K455). Immune complexes were dena-
tured, eluted, and reimmunoprecipitated with K455. Following sepa- downstream of Nef targeting to the TGN, since
ration on SDS-PAGE, biotinylated [35S]MHC-I was quantified by LY294002 has no effect on the TGN localization of Nef
fluorography. Bar graph shows quantitation of TGN-to-PM transport (Figure 5B). Next, GTP hydrolysis of PI3K/ARNO-acti-
of newly synthesized MHC-I biotinylated at 37C in cells expressing
vated ARF6 would stimulate the AP2/dynamin/clathrin-proteins indicated in the top panel. Efficiency of TGN-to-PM export
independent endocytosis of MHC-I into the Pq-sensi-in cells expressing adenovirus tet-transactivator alone is normalized
tive, ARF6-T27N-restricted endosomal compartmentto a value of one, and corresponding values for other expressed
proteins are calculated accordingly. Bars represent an average of (Figure 4). No known coat has yet been identified on
three independent experiments. Error bars indicate SD. ARF6-containing endosomal vesicles (Peters et al.,
(B) HeLa-CD4 cells were infected with either VV:WT or recombinant 2001). However, since ARF6 activates phospholipase D
vv expressing either HIV-1 Nef or KHSV K5 for 12 hr (moi  2). Cells
(for review, see Chavrier and Goud, 1999), at least somewere biotinylated on ice, transferred to 37C to allow internalization,
of the components required for formation of COP- andand harvested at indicated times. Biotinylated MHC-I was quantified
clathrin-coated vesicles may be used for the ARF6-as described in Experimental Procedures. Inset: steady-state levels
of MHC-I versus -tubulin in the cells infected with either VV:WT, mediated budding of vesicles from the plasma mem-
VV:Nef, or VV:K5. brane. After internalization of MHC-I into the Pq-sensi-
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tive ARF6 compartment, M20 within Nef facilitates se- ods used to evaluate cell surface expression of MHC-I,
it has long been thought that MHC-I is statically retainedquestering of MHC-I to the TGN, at least in part by
impeding the recycling of class I molecules from the at the cell surface. However, we exploited a quantitative
cell surface biotinylation assay to show that MHC-I wasARF6 compartment to the cell surface (Figure 4), a step
mimicked by Pq treatment of cells expressing NefM20A constitutively endocytosed and recycled in multiple cell
systems including HIV-1 permissive CD4 T cells (Fig-(Figure 4). We do not know how M20 blocks recycling
of MHC-I. However, the M20-containing Nef N-terminal ures 2 and 4 and see Supplemental Figure S1 at http://
www.cell.com/cgi/content/full/111/6/853/DC1). More-domain binds to Lck (Baur et al., 1997), which binds to
paxillin (Ostergaard et al., 1998) and may potentially over, we found that MHC-I endocytosis was selectively
blocked by a dominant-negative ARF6-Q67L, whereasregulate a paxillin-associated ARF6 GAP that controls
sorting of MHC-I to plasma membrane (Matafora et al., MHC-I recycling was impaired by a dominant-negative
ARF6-T27N deficient in GDP exchange (Figure 2). Our2001). Finally, whether Nef or PACS-1 or both directly
mediate the trafficking of internalized MHC-I from the results are in agreement with other studies (Reid and
Watts, 1990; Le Gall et al., 2000) that have also docu-ARF6 compartment to the TGN is currently under investi-
gation. mented the dynamic recycling of MHC-I in various cell
types, and suggest that MHC-I recycling via the ARF6Whereas we previously detected interaction between
the Nef acidic cluster, 62EEEE65, and PACS-1 both in GST pathway is a ubiquitous process. The physiological sig-
nificance of endocytosis and recycling of class I mole-pull-down experiments and in cell extracts (Piguet et
al., 2000), we were unable to detect direct binding of cules is not well recognized. However, recent reports
demonstrate the loading of recycling class I moleculeseither Nef or PACS-1 to ARF6 (data not shown). Nef
and PACS-1 may therefore activate the ARF6 pathway with exogenous peptides in endosomal compartments
(Gromme et al., 1999) and that this reloading can elicitindirectly, and our data suggest one key effector impli-
cated in this process is the class Ia PI3K, p85/p110. CTL responses both in vivo and in vitro (Jondal et al.,
1996), implying that perturbation of the MHC-I recyclingHowever, despite the presence of an SH3 domain within
the p85 regulatory subunit, studies using Nef-containing pathway by HIV-1 Nef may contribute to the immunoeva-
siveness of HIV-1.reporter molecules indicate sequences distinct from the
72PXXP75 motif mediate binding of Nef to p85/p110 (Lin- Surprisingly, HIV-1 Nef does not block export of MHC-I
from the TGN but relies solely on directing the efficientnemann et al., 2002). Moreover, as class I PI3Ks are
localized to the cell periphery (Venkateswarlu et al., endocytosis of MHC-I followed by sequestering the en-
docytosed class I molecules to the TGN (Figures 4 and1998), a direct activation of PI3K by Nef does not explain
the prerequisite for the PACS-1/62EEEE65-dependent 6). Why newly synthesized MHC-I molecules en route
to the cell surface are not blocked by HIV-1 Nef in thesorting of Nef to the TGN for the 72PXXP75-mediated
activation of ARF6, which controls downstream ef- TGN remains to be determined. Perhaps MHC-I may
need to be posttranslationally modified at the cell sur-fectors that stimulate MHC-I internalization. Why, then,
might PACS-1-dependent Nef targeting to the TGN be face, such as by phosphorylation, to be efficiently down-
regulated by Nef/PACS-1 (Capps and Zuniga, 2000).required for ARF6 activation? A possible explanation is
that PACS-1 targets Nef to the TGN where the viral Nonetheless, this Nef-mediated targeting of MHC-I to
the TGN is unprecedented, yet it is necessary for theprotein can recruit an activator of PI3K. One candidate
activator is the SH3 domain-containing Src family tyro- virus to evade immune surveillance by CD8 CTLs (Col-
lins et al., 1998; Le Gall et al., 2000). Moreover, oursine kinase Hck, since inactivation of this kinase abol-
ishes Nef-induced MHC-I downregulation (Chang et al., data suggest that HIV antigens are presented at the cell
surface in virally infected cells but fail to elicit efficient2001). Recent studies show that Hck isoforms are local-
ized to the Golgi and their binding to Nef stimulates Hck CTL killing because Nef can exploit the ARF6 sorting
pathway to rapidly remove MHC-I-peptide complexesactivation (Carreno et al., 2000; Lerner and Smithgall,
2002). Whether Nef/Hck complexes can recruit/activate (pMHC-I) and sequester them in the TGN. The reduced
cell surface levels of pMHC-I in HIV-infected cells mayPI3K directly or via intermediate signaling molecules
warrants further investigation. Additionally, whether select for the expansion of only a subset of high-affinity
CD8 cells directed against HIV epitopes, because theARNO or perhaps another ARF6 GEF, such as
cytohesin-1 or EFA6, stimulates the ARF6 endocytic availability of specific pMHC-I complexes at the cell
surface can be limiting for CD8 cell activation (Kedl etpathway in HIV-infected cells also remains to be estab-
lished. Given the roles of GTP/GDP exchange of ARF6 al., 2002). Moreover, the Nef/PACS-1-mediated down-
regulation of cell surface MHC-I in combination with thein phagocytosis within macrophages (Zhang et al.,
1998), in -arrestin-stimulated endocytosis of 2-adren- Nef-induced increase of cell surface FasL (Xu et al.,
1999) may impede CD8 recognition of poorly repre-ergic receptor (Claing et al., 2001), and in constitutive
endocytosis of the interleukin-2 receptor  chain (Tac) sented antigenic peptides on HIV-1-infected cells while
promoting Fas-mediated apoptotic death of those CD8(Radhakrishna and Donaldson, 1997), the ARF6-medi-
ated endosomal pathway may represent a major alterna- cells that can recognize infected cells despite reduced
surface expression of MHC class I (Fackler and Baur,tive to the more commonly studied clathrin-dependent
pathway. Significantly, pirating of the ARF6 pathway by 2002). To what extent these and other factors explain
the paradoxical relationship between the ability of HIV-1Nef appears to specifically target MHC-I for downregula-
tion as Nef has no effect on the steady-state distribution to successfully evade the immune system despite a ro-
bust CTL response early in infection warrants furtherof Tac/CD25, which shares the same sorting itinerary
as MHC-I (Schibeci et al., 2000, and data not shown). investigation. Nonetheless, our identification of the cel-
lular pathway controlling the Nef-induced MHC-I down-Based on a preponderance of nonbiochemical meth-
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ARF6-ha were extracted with phenol/chloroform, resolved on poly-regulation provides new insights into the mechanisms
ethyleneimine cellulose plates (Macherey-Nagel) using 0.8 Mof HIV immunoevasion and may foster new strategies
KH2PO4 (pH 3.5), and quantified by Phosphorimage analysis usingto combat HIV infection.
NIH Image software. The positions of [32P]GTP and [32P]GDP were
identified using extracts from cells expressing either ARF-Q67L
Experimental Procedures
(GTP) or ARF6-T27N (GDP).
Cell Lines, Recombinant DNA Constructs, Vaccinia
Immunofluorescence MicroscopyViruses, and Adenoviruses
Cells were fixed and processed for immunofluorescence as pre-HeLa-CD4, BSC-40, and A7 melanoma cells were maintained as
viously described (Piguet et al., 2000; Crump et al., 2001). Stainingdescribed (Crump et al., 2001). 293T cells were cultured in DMEM
was performed with primary antibodies against MHC-I (mAb W6/supplemented with 10% FBS. cDNAs and recombinant vaccinia
32, 1:100), CD4 (mAb Ab4, Pharmingen; 1:100), TGN46 (Serotec,viruses (vv) encoding for HIV-1 Nef (strain HXB2D), NefE4A, PACS-1,
1:50), PLAP (Biomeda; 1:500), AP-1 (mAb 100/3, Sigma; 1:100), orand PACS-1Admut were generated as described (Piguet et al., 2000;
the HA (mAb 16B12, Babco; 1:1000) or FLAG (mAb M2, Sigma;Crump et al., 2001), and KHSV K5 was provided by K. Fru¨h (OHSU).
1:1000) epitopes. To visualize Nef constructs, cells were permeabil-Plasmids expressing ARF6-Q67L-ha and ARF6-T27N-ha were pro-
ized with cytosol extraction buffer (0.5% saponin, 80 mM PIPES-vided by J. Donaldson (NIH). The 2-D176A-ha cDNA was provided
KOH [pH 6.8], 5 mM EGTA, 1 mM MgCl2) for 5 min prior to fixation.by S. Sorkin (UCHSC, Denver, CO). The HIV-1 proviral cDNA clone
Following incubation with fluorescently labeled secondary antibod-pHXBnPLAP-IRES-N that expresses placental alkaline phospha-
ies (Southern Biotech), images were captured using 63 oil immer-tase (PLAP) was obtained from the NIH AIDS Research and Refer-
sion objective on a Leica DM-RB or Zeiss Axioplan 2 microscope.ence Reagent Program. cDNAs encoding NefAXXA, NefM20A,
NefE4A-PACS-1, NefAXXA-PACS-1, and NefAXXA-PI3K* (a chimera
containing the constitutively active PI3K [p110*, provided by P. Acknowledgments
Rotwein, OHSU] fused to the C terminus of NefAXXA) were con-
structed by a site-directed PCR mutagenesis. VV and adenovirus The authors are grateful to J. Donaldson, M. Czech, J. Casanova,
recombinants were made as described (Hitt et al., 1997; Wan et al., P. Rotwein, A. Klippel, D. Cutler, K. Fru¨h, and A. Sorkin for reagents.
1998). We are also very thankful to A. Moses, A. Bakke, D. Lewinsohn,
A. Farnsworth, L. Hall, and W. Henderson for helpful advice and
HIV-1 Production and Infections participation in the early stages of this project. We thank C. Enns,
293T cells were transfected with pHXBnPLAP-IRES-N and viral D. Parker, A. Hill, and members of the Thomas lab for helpful sugges-
supernatants were harvested 36–72 hr later and stored at 	70C. tions and careful reading of the manuscript. The authors are sup-
Cells were infected with HIV-1 (moi  0.05) in the presence of poly- ported by fellowships from the HFSP and the Pathological Society
brene (4 g/ml) for 24 hr, washed, and cultured for 3 days. HIV-1- of Great Britain and Ireland (A.D.B.), Association pour la Recherche
infected cells were detected by expression of PLAP. contre le Cancer (S.F.F.), and NIH grants AI49793, AI8585, and
DK37274 (G.T.).
Transport Assays
Internalization Assay
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Cells were infected with recombinant vv (moi  10), cultured for 4
Revised: November 4, 2002
hr at 37C, and then biotinylated as described (Blagoveshchenskaya
et al., 1998). To follow the kinetics of MHC-I degradation, cells were
Referencesbiotinylated using noncleavable NHS-LC-biotin (Pierce). Cells were
lysed in mRIPA buffer (1% NP-40, 1% sodium deoxycholate, 150
Baur, A.S., Sass, G., Laffert, B., Willbold, D., Cheng-Mayer, C., andmM NaCl, 50 mM Tris-HCl [pH 8.0], and protease inhibitors [Sigma]),
Peterlin, B.M. (1997). The N-terminus of Nef from HIV-1/SIV associ-and biotinylated proteins were collected on streptavidin-agarose
ates with a protein complex containing Lck and a serine kinase.beads, washed, denatured, and resolved by SDS-PAGE. Biotinyl-
Immunity 6, 283–291.ated MHC-I were quantified by Western blot with pAb anti-MHC-I
K455 (K. Fru¨h, OHSU). CD4 internalization was measured using 100 Beraud-Dufour, S., Robineau, S., Chardin, P., Paris, S., Chabre, M.,
ng/ml mAb 125I-Q4120 (D. Cutler, UCL), essentially as described (Bla- Cherfils, J., and Antonny, B. (1998). A glutamic finger in the guanine
goveshchenskaya et al., 1999). nucleotide exchange factor ARNO displaces Mg2 and the beta-
Recycling Assay phosphate to destabilize GDP on ARF1. EMBO J. 17, 3651–3659.
MHC-I recycling was measured essentially as described (Reid and
Blagoveshchenskaya, A.D., Hewitt, E.W., and Cutler, D.F. (1998). A
Watts, 1990). Cells were infected and biotinylated as above, then
balance of opposing signals within the cytoplasmic tail controls the
shifted to 37C for 1 hr in the presence of 0.3 mM Pq. Cell surface
lysosomal targeting of P-selectin. J. Biol. Chem. 273, 27896–27903.
NHS-SS-Biotin (Pierce) was cleaved with reduced glutathione (GSH)
Blagoveshchenskaya, A.D., Hewitt, E.W., and Cutler, D.F. (1999). Di-buffer (50 mM GSH, 75 mM NaCl, 75 mM NaOH [pH 8.0], 10% FBS)
leucine signals mediate targeting of tyrosinase and synaptotagminon ice. Cells were then moved to 37C for 0, 1, 2, 4, and 8 min and
to synaptic-like microvesicles within PC12 cells. Mol. Biol. Cell 10,subjected to a second GSH treatment. Cells were then quenched
3979–3990.on ice with 5 mg/ml iodoacetamide, rinsed, and lysed in mRIPA
buffer. Biotinylated MHC-I molecules were collected and analyzed Capps, G.G., and Zuniga, M.C. (2000). Phosphorylation of class I
as described above. The steady-state level of internalized, biotinyl- MHC molecules in the absence of phorbol esters is an intracellular
ated MHC-I at zero time point of the second recycling chase at 37C event and may be characteristic of trafficking molecules. Mol. Immu-
was defined as 100%. The efficiency of recycling was defined as nol. 37, 59–71.
the ratio between the amount of biotinylated MHC-I at each time Carl, S., Greenough, T.C., Krumbiegel, M., Greenberg, M., Skowron-
point compared to that at zero time. ski, J., Sullivan, J.L., and Kirchhoff, F. (2001). Modulation of different
human immunodeficiency virus type 1 Nef functions during progres-
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